[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357224-105":59,"doc-detail-357224-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gc-ms-guided-phytochemical-profiling-of-bauhinia-tomentosa-flowers-molecular-docking-against-hpv-e6-and-p53-in-cervical-cancer","GC-MS guided phytochemical profiling of Bauhinia tomentosa flowers - molecular docking against HPV-E6 and p53 in cervical cancer","","GC-MS profiling was used to identify flower-derived phytochemical constituents from Bauhinia tomentosa and link them to in silico anticancer potential. Methanolic extracts yielded 45 metabolites spanning furanones, phenolics, fatty acids, phytosterols, and triterpenes, with stigmasterol, γ-sitosterol, and related derivatives among the major components. Molecular docking against HPV-E6 and p53 showed γ-sitosterol as the strongest binder, followed by lupeol and stigmasterol. ADMET predictions supported oral bioavailability and low toxicity, with attention to mild CYP450 inhibition and hepatotoxicity signals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gc-ms-guided-phytochemical-profiling-of-bauhinia-tomentosa-flowers-molecular-docking-against-hpv-e6-and-p53-in-cervical-cancer/357224/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gc-ms-guided-phytochemical-profiling-of-bauhinia-tomentosa-flowers-molecular-docking-against-hpv-e6-and-p53-in-cervical-cancer/357224.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What approach was used to profile Bauhinia tomentosa flower compounds in this study?","Question",{"text":112,"@type":113},"Methanolic flower extracts were analyzed using GC-MS, followed by molecular docking, ADMET assessment, and druglikeness evaluation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which identified metabolite showed the strongest binding in docking against HPV-E6 and p53?",{"text":117,"@type":113},"γ-Sitosterol showed the strongest binding, with docking energies of approximately -7.8 kcal/mol for HPV-E6 and -7.5 kcal/mol for p53.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the ADMET predictions indicate about oral bioavailability and toxicity?",{"text":121,"@type":113},"ADMET predictions suggested favorable oral bioavailability, high gastrointestinal absorption, and low toxicity overall, while sterols showed mild CYP450 inhibition and bis(2-ethylhexyl) phthalate indicated hepatotoxicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357224,1790261699,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nGC-MS guided phytochemical profiling of Bauhinia tomentosa flowers: molecular docking against HPV-E6 and p53 in cervical cancer  \nSelvaraj Trisha1 & Raju Balaji2􀀍  \nCervical cancer remains a major cause of mortality among women in low-and middle-income countries, highlighting the need for affordable plant-based therapeutics. Bauhinia tomentosa (Mantharai), traditionally used for inflammatory and anticancer applications, has not been systematically explored for flower-derived anticancer compounds. In this study, methanolic flower extracts were profiled using GC-MS, followed by molecular docking, ADMET assessment, and druglikeness evaluation. GC-MS analysis identified 45 metabolites, including furanones, phenolics, fatty acids, phytosterols, and triterpenes. Major constituents included stigmasterol (18.28%), γ-sitosterol (12.28%), 5-hydroxymethylfurfural (14.01%), and 4-H-pyran-4-one derivatives (13.68%) . Docking against cervical cancer targets HPV-E6 (PDB: 4XR8) and p53 (PDB: 1TUP) revealed γ-sitosterol asthe strongest binder (-7.8 and − 7.5 kcal/mol, respectively), followed by lupeol and stigmasterol, outperforming cisplatin and comparable to bicalutamide. ADMET predictions indicated favorable oral bioavailability, high gastrointestinal absorption, and low toxicity, although sterols exhibited mild CYP450 inhibition and bis(2-ethylhexyl) phthalate showed hepatotoxicity. This study presents the first integrated phytochemical and in silico evaluation of B. tomentosa flowers, identifying γ-sitosteroland related phytosterols as promising lead molecules for cervical cancer therapy, warranting further experimental validation.  \nKeywords Bauhinia tomentosa, GC-MS, Cervical cancer, Molecular docking, Phytosterols, Lupeol  \nCervical cancer is a major global health concern, ranking as the fourth most common cancer in women and one of the leading causes of mortality in low-and middle-income countries. Its incidence is particularly high in South Asia and Sub-Saharan Africa, where barriers to early screening, HPV vaccination, and adequate treatment contribute to its prevalence. According to the National Cancer Registry Programme of India, cervical cancer remains the second most common cancer among Indian women, with projections suggesting more than 85,000 new cases annually by 20251. Persistent infection with high-risk human papillomavirus (HPV) types, especially HPV-16 and HPV-18, underlies nearly all cases of cervical carcinogenesis, primarily through viral oncoproteins E6 and E7. Although p53 is widely implicated across cancers, in HPV-positive cervical cancer it is specifically inactivated through HPV-E6–driven ubiquitin-mediated degradation, making the E6–p53 axis a defining hallmark of HPV-driven cervical carcinogenesis2–4. These oncoproteins inactivate tumor suppressors such as p53 and Rb, thereby promoting genomic instability and malignant transformation5. Approaches that inhibit E6 or rescue p53 activity have been shown to restore p53-p21 signalling and trigger apoptosis in HPV-positive cervical cancer models6,7. High-risk HPV-E6 promotes cervical carcinogenesis by recruiting E6AP to ubiquitinate and degrade the tumour suppressor p53, thereby disabling DNA-damage-induced cell-cycle arrest and apoptosis2–4. Despite the availability of chemotherapeutic drugs such as cisplatin and cyclophosphamide, their clinical success is limited by systemic toxicity, drug resistance, and non-specific cytotoxicity8,9. Thus, the search for safer, plant-derived anticancer agents capable of modulating HPV-driven oncogenesis remains an urgent biomedical priority10.  \n1Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu 602105, India. 2Molecular Biology and Genomics Lab, Department of Orthopaedics, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Scien","cbCaipQ74ENwmI7B","https://ap.wps.com/l/cbCaipQ74ENwmI7B","pdf",2367935,13,"English","# Introduction\n## Cervical cancer background and HPV-E6/p53 axis\n## Limitations of current chemotherapy\n# Materials and Methods\n## GC-MS phytochemical profiling\n## Molecular docking and target selection\n## ADMET and druglikeness evaluation\n# Results\n## GC-MS metabolite identification\n## Docking performance against HPV-E6 and p53\n## ADMET and toxicity considerations\n# Conclusion","[{\"question\":\"What approach was used to profile Bauhinia tomentosa flower compounds in this study?\",\"answer\":\"Methanolic flower extracts were analyzed using GC-MS, followed by molecular docking, ADMET assessment, and druglikeness evaluation.\"},{\"question\":\"Which identified metabolite showed the strongest binding in docking against HPV-E6 and p53?\",\"answer\":\"γ-Sitosterol showed the strongest binding, with docking energies of approximately -7.8 kcal/mol for HPV-E6 and -7.5 kcal/mol for p53.\"},{\"question\":\"What did the ADMET predictions indicate about oral bioavailability and toxicity?\",\"answer\":\"ADMET predictions suggested favorable oral bioavailability, high gastrointestinal absorption, and low toxicity overall, while sterols showed mild CYP450 inhibition and bis(2-ethylhexyl) phthalate indicated hepatotoxicity.\"}]","GC-MS guided phytochemical profiling of Bauhinia tomentosa flowers - molecular docking against HPV-E6 and p53 in cervical cancer | PDF",1790129390,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/249e98309c540edaf2b777b5ed98fcda.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5811969fca62bbbef898aa0d1a9c209a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3417fce256c3d0d5dc132295ba576f7c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/baeb49840e3beca28338e0ba576f70ca.webp",980,1287]